There's no inconsistency with holding while being a little sceptical, so please don't use the spurious retort again gekkowolf. I'm "Doing My Own Research" and looking for independent credible sources to help understand the osl panco data a bit more, as I would do with any biotech.
As you seem so certain of things, here are a couple of questions:
1. What's OSL's response when a Professor of Oncology asks a company representative: Does your panco trial confirm your device provided efficacy benefit over and above the results we already get with current chemotherapy and/or does it show it is better (more effective) than standard radiotherapy in head to head trial? If not, why should I use it?
2. What's OSL's response to the head of a reimbursement agency (let's say N.I.C.E. in UK) when asked: Does your panco trial confirm your device provided efficacy benefit over and above current chemotherapy and/or does it show it is better (more effective) than standard radiotherapy in a head to head trial? If not, why should we pay a premium for it?
- Forums
- ASX - By Stock
- Ann: Oncosil breakthrough device receives CE Marking approval
There's no inconsistency with holding while being a little...
-
-
- There are more pages in this discussion • 65 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add OSL (ASX) to my watchlist
|
|||||
Last
1.1¢ |
Change
0.001(4.76%) |
Mkt cap ! $41.62M |
Open | High | Low | Value | Volume |
1.0¢ | 1.1¢ | 1.0¢ | $36.16K | 3.384M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
25 | 14154999 | 1.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.1¢ | 5667943 | 6 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
25 | 14154999 | 0.010 |
21 | 12098472 | 0.009 |
9 | 6587500 | 0.008 |
7 | 3264285 | 0.007 |
9 | 8595001 | 0.006 |
Price($) | Vol. | No. |
---|---|---|
0.011 | 5667943 | 6 |
0.012 | 6817838 | 11 |
0.013 | 11057332 | 6 |
0.014 | 5769139 | 8 |
0.015 | 8500000 | 3 |
Last trade - 16.10pm 30/08/2024 (20 minute delay) ? |
Featured News
OSL (ASX) Chart |
The Watchlist
CCO
THE CALMER CO INTERNATIONAL LIMITED
Anthony Noble, MD & CEO
Anthony Noble
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online